Amy L Pasternak

13PUBLICATIONS
42CO-AUTHORS
Correctional theory, offender treatment and rehabilitationHaematological tumoursPharmacogenomicsPredictive and prognostic markersRadiology and organ imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 16, 2026
Differences in Early Tacrolimus Exposure in Kidney Transplant Recipients With and Without CYP3A5 Genotype-Guided Tacrolimus Dosing.

|Feb 27, 2026
Identification of Additional DPYD Polymorphisms That Increase the Risk of Severe Fluoropyrimidine Toxicity and Improve Predictive Accuracy when Combined with Previously Validated Variants.

Nam Nguyen-Hoang, Kelly Nugent, Sophia Jaso

|Apr 10, 2025
Survey of the utilization of genotype-guided tacrolimus management in United States solid organ transplant centers.

Ashton Strother, Jeong M Park, Amy L Pasternak

|Dec 07, 2023
Risk of Toxicity From Topical 5-Fluorouracil Treatment in Patients Carrying DPYD Variant Alleles.

Javier Granados, Amy L Pasternak, N Lynn Henry

|Dec 13, 2022
Identifying the prevalence of clinically actionable drug-gene interactions in a health system biorepository to guide pharmacogenetics implementation services.

Amy L Pasternak, Kristen Ward, Madison Irwin

|Mar 03, 2022
Survey of US Medical Oncologists' Practices and Beliefs Regarding DPYD Testing Before Fluoropyrimidine Chemotherapy.

Kyoin Koo, Amy L Pasternak, N Lynn Henry

Pageof 3

Frequent Collaborators

5 joint publications

Daniel L Hertz

4 joint publications

Jeong M Park

3 joint publications

Faisal Shakeel

3 joint publications

N Lynn Henry